Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·+0.63%·₹456.75
Key EventTrading window closure announced for insiders
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-1.78%·₹452.4
Key EventUSFDA inspection completed with five observations issued
ImpactInvestors should monitor CAPA progress and potential impact on US market accessSign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·+5.15%·₹460.6
Key EventInvestment in CCPS of NJ Bio Inc. completed
ImpactThis strategic investment strengthens Cohance's position in the ADC CRDMO market and supports subsidiary growth.Sign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-0.52%·₹438.05
Key EventAll three AGM resolutions passed with requisite majority
ImpactShareholders approved key financial reports and director reappointment, confirming governance continuity.Sign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-0.52%·₹438.05
Key Event8th AGM approved financial statements and reappointed Ms. Shweta Jalan as director.
ImpactShareholders approved key financials and leadership continuity, signaling confidence in the company's direction.Sign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-0.52%·₹438.05
ImpactInvestors can expect increased engagement with global analysts and potential insights into growth plans.Sign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-1.57%·₹449.4
Key EventUSFDA inspection completed with four observations issued
ImpactThe inspection outcome may delay product launches but the company is actively addressing findings to maintain compliance.Sign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-0.78%·₹456.55
Key EventBoard approves acquisition of additional NJ Bio shares and controlling investment in Aruka Bio
ImpactThese moves deepen Cohance's ADC focus and could drive future growth through integrated services and pipeline partnershipsSign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-0.78%·₹456.55
Key EventCohance advances ADC strategy with USD 18 million total investment in NJ Bio and Aruka Bio
ImpactThese moves deepen Cohance's control over its ADC platform and clarify leadership focus for future growth.Sign up to read impact
Cohance Lifesciences Ltd (COHANCE)
·Next Day Close·-0.73%·₹450.65
Key EventCompany to present at Elara India Dialogue conference on September 1
ImpactInvestors can expect direct engagement with management during the conference sessions.Sign up to read impact